Perrigo (PRGO) Announces Receipt of Final FDA Approval for Generic KlorCon Tabs
Perrigo (NYSE: PRGO) announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration ("FDA") ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
